CN101618042A - Medicament for treating herpes and neurodermatitis - Google Patents

Medicament for treating herpes and neurodermatitis Download PDF

Info

Publication number
CN101618042A
CN101618042A CN200810048303A CN200810048303A CN101618042A CN 101618042 A CN101618042 A CN 101618042A CN 200810048303 A CN200810048303 A CN 200810048303A CN 200810048303 A CN200810048303 A CN 200810048303A CN 101618042 A CN101618042 A CN 101618042A
Authority
CN
China
Prior art keywords
neurodermatitis
herpes
medicine
cortisone acetate
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810048303A
Other languages
Chinese (zh)
Inventor
江燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200810048303A priority Critical patent/CN101618042A/en
Publication of CN101618042A publication Critical patent/CN101618042A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a medicament for treating herpes and neurodermatitis, which is prepared from the following components in percentage by weight: 0.2 to 0.6 g of chlorpheniramine maleate, 0.8 to 1.2 g of fosfomycin sodium, 0.01 to 0.02 g of cortisone acetate eye drops, 8 to 12 g of compositus mentholi cream and 8 to 12 g of triamcinolone acetonide acetate and miconazole nitrate and neomycin sulfate cream. The medicament for treating the herpes and the neurodermatitis has the advantages of good treatment effects on herpes, neurodermatitis, beriberi, psoriasis and cutaneous pruritus, quick response and short healing time.

Description

A kind of medicine for the treatment of herpes and neurodermatitis
Technical field
The present invention relates to medicine field.Relate in particular to a kind of medicine for the treatment of herpes and neurodermatitis.
Background technology
At present, the medicine of treatment herpes and neurodermatitis is many, but general curative effect is good inadequately, and treatment time is long.
Summary of the invention
Purpose of the present invention is exactly a kind of eutherapeutic treatment herpes that provides at the above-mentioned deficiency of medicine of present treatment herpes and neurodermatitis and the medicine of neurodermatitis
The present invention is made up of chlorphenamine maleate, fosfomycin sodium, cortisone acetate eye drop, WUJI GAO, QUMIXIN emulsifiable paste; Its weight portion proportioning is:
Chlorphenamine maleate 0.2-0.6g WUJI GAO 8-12g QUMIXIN emulsifiable paste 8-12g
Fosfomycin sodium 0.8-1.2g cortisone acetate eye drop 0.01-0.02g.
Its optimum weight part proportioning is:
Chlorphenamine maleate 0.4g WUJI GAO 10g QUMIXIN emulsifiable paste 10g
Fosfomycin sodium 1g cortisone acetate eye drop 0.015g.
Cortisone acetate eye drop can replace with cortisone acetate.
Advantage of the present invention is: good to herpes and neurodermatitis, vitamin B1 deficiency, tinea, skin pruritus therapeutic effect, and instant effect, healing time is short.
The specific embodiment
Make the milky mastic after getting commercially available Chlorate (being ground into powder) 0.4g, WUJI GAO (the electrodeless pharmaceutcal corporation, Ltd in ZhangZhou produces) 10g, QUMIXIN emulsifiable paste (Guangdong Shunfeng Pharmaceutical Co., Ltd's production) 10g, commercially available fosfomycin sodium 1g and commercially available cortisone acetate eye drop 0.015g mixing.During use it is coated in the affected part, can heals in the lighter 5-7 days every day 2-5 time, can heal in weight person 15-25 days.
Clinical case:
1, Chen Yuling: the woman, 34 years old, people from Zhongxiang City, Hubei pointed the back of the hand in March, 2007 and suffers from pompholyx, and use this medicine to be applied to the affected part in July, 2007, every day 2-3 time, recovery from illness in 5-7 days.
2, Fan Demei: the woman, 60 years old, people from Zhongxiang City, Hubei, in JIUYUE, 1999 hands, foot are suffered from neurodermatitis, skin pruritus, fall ill annual spring and autumn repeatedly, uses this medicine to be applied to the affected part in April, 2005, every day 4-5 time, obviously alleviated recovery from illness after 12 days, and no longer recurrence in 12 days.
3, Chen Deqing: the man, 48 years old, people from Zhongxiang City, Hubei, in March, 2008, hands was suffered from pompholyx, used this medicine to be applied to the affected part, every day 2-3 time, recovery from illness after 7 days.
4, Lu Jun: the man, 42 years old, people from Zhongxiang City, Hubei, in October, 2007, foot was suffered from vitamin B1 deficiency, through repeatedly therapeutic effect is bad, used this medicine to be applied to the affected part, and every day 2-3 time, the state of an illness was clearly better in 10 days, recovery from illness after 14 days.
5, Dong Hang: the man, 12 years old, people from Zhongxiang City, Hubei, the long tinea of in JIUYUE, 2007 shank, pruritus through repeatedly therapeutic effect is invalid, uses this medicine to be applied to the affected part, and every day 2-3 time, the state of an illness was clearly better in 5 days, recovery from illness after 10 days.

Claims (3)

1, a kind of medicine for the treatment of herpes and neurodermatitis is characterized in that it is made up of chlorphenamine maleate, fosfomycin sodium, cortisone acetate eye drop, WUJI GAO, QUMIXIN emulsifiable paste; Its weight portion proportioning is:
Chlorphenamine maleate 0.2-0.6g WUJI GAO 8-12g QUMIXIN emulsifiable paste 8-12g fosfomycin sodium 0.8-1.2g cortisone acetate eye drop 0.01-0.02g.
2, want the medicine of 1 described treatment herpes and neurodermatitis according to right, it is characterized in that its optimum weight part proportioning is:
Chlorphenamine maleate 0.4g WUJI GAO 10g QUMIXIN emulsifiable paste 10g fosfomycin sodium 1g cortisone acetate eye drop 0.015g.
3, want the medicine of 1 or 2 described treatment herpess and neurodermatitis according to right, it is characterized in that cortisone acetate eye drop can replace with cortisone acetate.
CN200810048303A 2008-07-01 2008-07-01 Medicament for treating herpes and neurodermatitis Pending CN101618042A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810048303A CN101618042A (en) 2008-07-01 2008-07-01 Medicament for treating herpes and neurodermatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810048303A CN101618042A (en) 2008-07-01 2008-07-01 Medicament for treating herpes and neurodermatitis

Publications (1)

Publication Number Publication Date
CN101618042A true CN101618042A (en) 2010-01-06

Family

ID=41511571

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810048303A Pending CN101618042A (en) 2008-07-01 2008-07-01 Medicament for treating herpes and neurodermatitis

Country Status (1)

Country Link
CN (1) CN101618042A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109602750A (en) * 2018-10-25 2019-04-12 广州市士刚食品有限公司 It is a kind of to treat dermopathic externally applied drug

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109602750A (en) * 2018-10-25 2019-04-12 广州市士刚食品有限公司 It is a kind of to treat dermopathic externally applied drug

Similar Documents

Publication Publication Date Title
AU2017250267A1 (en) Compositions for topical application of compounds
CN102258609B (en) Sanhuang antipruritic liniment and its preparation method
Rasheed et al. A review of natural steroids and their applications
CN110302414A (en) A kind of medical scar repairs silicone gel dressing and preparation method
CN102366437A (en) Compound dexamethasone ointment and preparation method thereof
CN104147533A (en) Blood-activating, stasis-resolving and pain-relieving cream and preparation method thereof
CN103191284A (en) Dragon blood spraying film agent applied to superficial wound and preparation technology thereof
CN101797298B (en) Ointment for treating eczema and preparation method thereof
MY179794A (en) Compound composition for inhalation used for treating asthma
KR0181763B1 (en) External therapeutic composition for dermatitis
CN101618042A (en) Medicament for treating herpes and neurodermatitis
Güven Different potent glucocorticoids, different routes of exposure but the same result: Iatrogenic Cushing’s syndrome and adrenal insufficiency
CN104940224A (en) Inhalation type pharmaceutical composition for treating Parkinson's disease and preparation method thereof
US20180353397A1 (en) Autophage activating resveratrol topical composition for skin improvement and treatment
US11759479B2 (en) Compositions comprising a manganese mineral and methods of use
Lalduhawma et al. Co-Relation of Steriods in Diabetic and COVID-19 Patients
DE102017215154A1 (en) Composition for the topical treatment of non-microorganism-caused inflammatory skin and mucous membrane diseases
CN102755608B (en) External application medicine for treating bronchitis
CN101829154A (en) Medicine composition for preventing and treating asthma
CN101129403A (en) Medicine composite for treating dermatopathy
CN1935157B (en) Medical stone emulsifiable paste for treating skin disease and its preparing method
CN106166180A (en) A kind of Chinese medicine composition treating oral ulcer and application thereof
CN101683369B (en) Medicament for treating skin tinea disease
JP2005104943A (en) Medicinal agent or functional food for suppressing/alleviating allergic disease
CN115054614A (en) Facial cleansing cream for radically treating facial acne and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100106